Journal
MODERN RHEUMATOLOGY
Volume 32, Issue 4, Pages 803-807Publisher
OXFORD UNIV PRESS
DOI: 10.1093/mr/roab054
Keywords
Familial Mediterranean fever; paediatric rheumatology; persistent inflammation
Categories
Ask authors/readers for more resources
This study investigated the predictors of persistent inflammation in children with familial Mediterranean fever (FMF). The results showed that M694V homozygosity, colchicine resistance, positive family history, and other factors may be independent predictors of persistent inflammation in FMF. These predictors can help clinicians suspect subclinical inflammation and improve disease management in FMF.
Objectives Persistent inflammation is an insidious feature of familial Mediterranean fever (FMF) that may cause chronic complications. This study aimed to investigate the predictors of persistent inflammation in children with FMF. Methods The medical charts of 1077 paediatric FMF patients were retrospectively collected. The patients were divided into two groups: with and without subclinical inflammation. Results A total of 133 (12%) patients had persistent inflammation. M694V homozygosity, colchicine resistance, positive family history for FMF, erysipelas-like erythema, leg pain, arthritis, chest pain, inflammatory comorbidities, early disease onset, high PRAS score, and long attack duration were established as independent predictors of persistent inflammation (P < .001, P < .001, P < .001, P < .001, P = 0.006, P < .001, P < .001, P = .014, P < .001, P < .001, and P < .001, respectively). However, gender, abdominal pain, fever, and attack frequency were not found to be independent risk factors for predicting persistent inflammation (P = .412, P = .531, P = .451, and P = .693, respectively). Conclusions M694V homozygosity, colchicine resistance, positive family history, erysipelas-like erythema, leg pain, arthritis, chest pain, inflammatory comorbidities, early disease onset, high activity score, and long attack duration may be predictors of persistent inflammation in FMF. These predictors may help clinicians suspect the occurrence of subclinical inflammation and should aid in better disease management in FMF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available